Overdiagnosis in Colorectal Cancer Screening - Time to Acknowledge A Blind Spot

Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) Jg. 155; H. 3; S. 592
Hauptverfasser: Kalager, Mette, Wieszczy, Paulina, Lansdorp-Vogelaar, Iris, Corley, Douglas A, Bretthauer, Michael, Kaminski, Michal F
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.09.2018
Schlagworte:
Overdiagnosis
Colorectal Cancer Screening
ISSN:1528-0012, 1528-0012
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there is a striking and almost complete lack of knowledge about overdiagnosis in colorectal cancer screening. Overdiagnosis is not part of patient information material, hardly mentioned in guidelines, and not addressed in scientific or public debate. The present paper proposes a semantic, conceptual and clinical framework for overdiagnosis in CRC screening.
Bibliographie:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1528-0012
1528-0012
DOI:10.1053/j.gastro.2018.07.037